- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Vera Bradley terminates shareholder rights plan early | ||
| Fr | ORIC presents preclinical data on prostate cancer drug at AACR | ||
| Fr | Theriva to present VCN-01 pancreatic cancer trial data at AACR | ||
| Fr | Paramount declares $0.05 quarterly dividend for shareholders | ||
| Fr | Adagene reports trial data for cancer drug muzastotug combos | ||
| Fr | Nuvalent presents zidesamtinib data in pre-treated lung cancer | ||
| Fr | Cardiff Oncology presents preclinical data on cancer drug combo | ||
| Fr | Aviation Capital Group CFO Craig Segor to step down May 31 | ||
| Fr | Blue Owl co-CEOs remove shares as collateral for margin loans, WSJ reports | ||
| Fr | Zai Lab stock rises on positive trial data for cancer drug | ||
| Fr | Evaxion stock jumps 8% on positive cancer vaccine trial data | ||
| Fr | Zentalis presents preclinical data on cancer drug azenosertib | ||
| Fr | Evaxion reports 86% immune response rate in cancer vaccine trial | ||
| Fr | Innate Pharma reports interim lung cancer trial results | ||
| Fr | Zymeworks presents preclinical data on ADC pipeline at AACR | ||
| Fr | Evaxion presents AI platform data for glioblastoma vaccine design | ||
| Fr | Moderna's melanoma therapy shows 83% response rate in trial | ||
| Fr | Orum presents preclinical data for AML drug candidate ORM-1153 | ||
| Fr | Why does Citi see Japanese stocks continuing to go higher? | ||
| Fr | Cosmos Health plans Q2 U.S. launch of curcumin supplement | ||
| Fr | UCB to acquire Neurona Therapeutics for up to $1.15 billion | ||
| Fr | Shareholders approve reorganization of two Innovator ETFs | ||
| Fr | Albemarle shares dive as lingering lithium supply issues worry investors | ||
| Fr | Freedom Broker raises Perma-Pipe stock price target on revenue growth | ||
| Fr | Genius Group closes $8M registered direct offering |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.